Clinical Trial Update: A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable Sarcomas [Phase 2]

View source ↗

Summary

Phase II trial of PM01183 as a single agent or with standard chemotherapy in metastatic/unresectable sarcoma completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• PM01183 (PM01183)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Metastatic Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2018-03-05